Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

    ... were observed in patients with lower baseline endogenous erythropoietin ≤ 500 mU/mL (34.0% v 15.5% for > 500 mU/mL). At week 12, ...

    Research Article last updated 07/18/2016 - 10:30am.

  2. Personalized medicine for MDS

    ... MDS and anemia who have a low (<500 U/L) erythropoietin level as well as low transfusion requirement.  Most ...

    Research Review last updated 05/02/2016 - 9:44am.

  3. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of thrombopoietin receptor agonists in aplastic anemia and myelodysplastic syndromes.

    ... white blood cells, in particular neutrophils, and erythropoietin , to stimulate red blood cell production, have been ...

    Research Review last updated 05/02/2016 - 9:21am.

  4. Growth Factors

    ... Red cell growth factor is called erythropoietin or EPO for short. It is a hormone naturally produced ...

    Topic section last updated 04/06/2016 - 12:37pm.

  5. Growth Factors

    ... therapy. Red cell growth factor is called erythropoietin or EPO for short. It is a hormone naturally produced in the liver. Man-made forms of erythropoietin come in the brand names Epogen and Procrit. Darbapoietin, is ...

    Page last updated 11/13/2014 - 9:34am.

  6. Epoetin Alfa

    ... bone marrow failure disease patients whose natural erythropoietin levels are low. It is given by injection under the skin ...

    Drug last updated 03/24/2016 - 12:32pm.

  7. Darbepoetin Alfa

    ... in bone marrow failure patients whose natural erythropoietin levels are low. It is given by injection under the skin ...

    Drug last updated 03/24/2016 - 12:32pm.

  8. Drugs

    ... A ranesp epoetin alfa ( Erythropoietin ) E pogen, P rocrit ...

    Page last updated 03/02/2016 - 9:11am.

  9. MEDALIST Trial

    ... ESA regimen must have been either recombinant human erythropoietin (rHu EPO) > 40,000 IU/wk for at least 8 doses or ... low chance of response to ESA base on endogenous serum erythropoietin level > 200 U/L for subjects not previously treated with ESAs ...

    Clinical Trial last updated 02/22/2017 - 11:42am.

  10. Sexuality and Intimacy

    ... fatigue and fever. Red cell growth factors like erythropoietin (Procrit® or Epogen®) can cause joint pain and headache. ...

    Page last updated 05/02/2016 - 10:09am.